House Energy & Commerce Hearing Leads Stakeholders To Prep For Possible Congressional Action

Lobbyists for hospitals and drugs makers say they would not be surprised if lawmakers take up a 340B bill to monitor how hospitals use the savings from the 340B drug discount program and to clarify which patients for whom hospitals may claim discounts. They base their suspicion on comments and questions from lawmakers at a recent House Energy & Commerce Committee health subcommittee hearing. Health subcommittee Chair Joe Pitts (R-PA) said at the end of the hearing that Congress has...